Clinical trial
Promoting Tolerance to Peanut in High-Risk Children
NCT00329784 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00329784 |
|---|---|
| Title | Promoting Tolerance to Peanut in High-Risk Children |
| Official title | Induction of Tolerance Through Early Introduction of Peanut in High-Risk Children (ITN032AD) |
| Acronym | LEAP |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Immune Tolerance Network (ITN) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Eczema, Egg Allergy, Food Allergy |
| Intervention type | Biological |
| Interventions | Peanut Consumption Group |
| Enrollment | 640 |
| Start date | Dec 1, 2006 |
| Primary completion | May 1, 2014 |
| Completion | May 1, 2014 |
| First posted | May 25, 2006 |
| Last update posted | Apr 17, 2019 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: